OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - MEDTRONIC Share Price

Certificat

DE000SD7FW92

Delayed Deutsche Boerse AG 02:33:33 12/06/2024 pm IST
6.35 EUR +0.47% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - MEDTRONIC
Current month-1.10%
1 month+1.44%
Date Price Change
12/24/12 6.35 +0.47%
11/24/11 6.32 +1.44%
10/24/10 6.23 +1.63%
07/24/07 6.13 -1.29%
06/24/06 6.21 -0.48%

Delayed Quote Deutsche Boerse AG

Last update June 12, 2024 at 02:33 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SD7FW9
ISINDE000SD7FW92
Date issued 07/04/2021
Strike 150.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.56
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.7
Lowest since issue 2.13
Spread 0.03
Spread %0.47%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.95 USD
Average target price
94.07 USD
Spread / Average Target
+14.79%
Consensus